share_log
Benzinga ·  May 3 13:34
Anixa Biosciences 13D Filing Shows President, COO & CFO Michael Catelani Reported A 5.25% Stake In The Co As Of April 30, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment